search
BioSpace
Trends
- 1Survey finds compliance concerns slowing AI adoption in drug manufacturing●Compliance concerns hinder rollout of AI in drug manufacturing: Survey
A new survey covered by BioSpace indicates that regulatory compliance worries are holding back the adoption of artificial intelligence in pharmaceutical manufacturing. Drugmakers see potential in AI to improve efficiency and quality control, but uncertainty around meeting regulatory requirements and validation standards is delaying wider rollout across production facilities, according to the findings.
- 2BioSpace honours 40 Under 40 shaping biopharma●BioSpace 40 Under 40 winners make their mark on biopharma
BioSpace has announced the winners of its 40 Under 40 programme, recognising young leaders making an impact across the biopharmaceutical industry. The honourees span research, development and commercial roles, and the list is intended to spotlight the next generation of executives and scientists driving innovation in drug development.